{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:33:57Z","timestamp":1780396437951,"version":"3.54.1"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>The objectives of this study were to evaluate incidence and to identify the risk factors of occurrence and the predictive factors of symptomatic forms of nodular regenerative hyperplasia (NRH) after liver transplantation (LT).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>To identify risk factors of NRH following LT, we included 1648 patients transplanted from 2004 to 2018 and compared the patients developing NRH after LT to those who did not. To identify predictive factors of symptomatic NRH, we selected 115 biopsies displaying NRH and compared symptomatic to asymptomatic forms. Symptomatic NRH was defined as the presence of ascites, esophageal varices, hepatic encephalopathy, portal thrombosis, retransplantation, or death related to NRH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>The incidence of NRH following LT was 5.1%. In multivariate analysis, the independent factor of developing NRH after LT was the donor\u2019s age (odds ratio [OR] = 1.02; confidence interval, 1.01-1.03; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.02). Symptomatic forms occurred in 29 (25.2%) patients: 19 (16.5%) patients presented with ascites, 13 (11.3%) with esophageal varices, 4 (3.5%) with hepatic encephalopathy, and 8 (7%) with portal thrombosis. The median period before the onset of symptoms was 8.4 (1.5\u201311.3) y after LT. The spleen size at diagnosis\/before LT ratio (OR = 12.5; 114.17-1.37; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0252) and thrombectomy during transplantation (OR = 11.17; 1.48-84.11; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0192) were associated with symptomatic NRH in multivariate analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>NRH following LT is frequent (5.1%) and leads to symptomatic portal hypertension in 25.2% of patients. Using older grafts increases the risk of developing NRH after LT. Clinicians should screen for signs of portal hypertension, particularly in measuring spleen size.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000004303","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T04:00:37Z","timestamp":1663560037000},"page":"410-419","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Nodular Regenerative Hyperplasia Is Not a Rare Condition After Liver Transplantation: Incidence, Predictive Factors, and Impact on Survival"],"prefix":"10.1097","volume":"107","author":[{"given":"Ilias","family":"Kounis","sequence":"first","affiliation":[{"name":"AP-HP H\u00f4pital Paul-Brousse, Centre H\u00e9pato-Biliaire, Villejuif, France."},{"name":"INSERM, Universit\u00e9 Paris-Saclay, UMR-S 1193, Villejuif, France."},{"name":"Universit\u00e9 Paris-Saclay, INSERM, Physiopathog\u00e9n\u00e8se et traitement des maladies du Foie, Villejuif, France."},{"name":"FHU Hepatinov, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myl\u00e8ne","family":"Sebagh","sequence":"additional","affiliation":[{"name":"INSERM, Universit\u00e9 Paris-Saclay, UMR-S 1193, Villejuif, France."},{"name":"Universit\u00e9 Paris-Saclay, INSERM, Physiopathog\u00e9n\u00e8se et traitement des maladies du Foie, Villejuif, France."},{"name":"FHU Hepatinov, Villejuif, France."},{"name":"Laboratoire d\u2019Anatomopathologie, AP-HP H\u00f4pital Paul-Brousse, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Evain","sequence":"additional","affiliation":[{"name":"AP-HP H\u00f4pital Paul-Brousse, Centre H\u00e9pato-Biliaire, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Cailliez","sequence":"additional","affiliation":[{"name":"AP-HP H\u00f4pital Paul-Brousse, Centre H\u00e9pato-Biliaire, Villejuif, France."},{"name":"INSERM, Universit\u00e9 Paris-Saclay, UMR-S 1193, Villejuif, France."},{"name":"Universit\u00e9 Paris-Saclay, INSERM, Physiopathog\u00e9n\u00e8se et traitement des maladies du Foie, Villejuif, France."},{"name":"FHU Hepatinov, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Roche","sequence":"additional","affiliation":[{"name":"AP-HP H\u00f4pital Paul-Brousse, Centre H\u00e9pato-Biliaire, Villejuif, France."},{"name":"INSERM, Universit\u00e9 Paris-Saclay, UMR-S 1193, Villejuif, France."},{"name":"Universit\u00e9 Paris-Saclay, INSERM, Physiopathog\u00e9n\u00e8se et traitement des maladies du Foie, Villejuif, France."},{"name":"FHU Hepatinov, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"De Martin","sequence":"additional","affiliation":[{"name":"AP-HP H\u00f4pital Paul-Brousse, Centre H\u00e9pato-Biliaire, Villejuif, France."},{"name":"INSERM, Universit\u00e9 Paris-Saclay, UMR-S 1193, Villejuif, France."},{"name":"Universit\u00e9 Paris-Saclay, INSERM, Physiopathog\u00e9n\u00e8se et traitement des maladies du Foie, Villejuif, France."},{"name":"FHU Hepatinov, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolphe","family":"Sobesky","sequence":"additional","affiliation":[{"name":"AP-HP H\u00f4pital Paul-Brousse, Centre H\u00e9pato-Biliaire, Villejuif, France."},{"name":"INSERM, Universit\u00e9 Paris-Saclay, UMR-S 1193, Villejuif, France."},{"name":"Universit\u00e9 Paris-Saclay, INSERM, Physiopathog\u00e9n\u00e8se et traitement des maladies du Foie, Villejuif, France."},{"name":"FHU Hepatinov, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Guettier","sequence":"additional","affiliation":[{"name":"INSERM, Universit\u00e9 Paris-Saclay, UMR-S 1193, Villejuif, France."},{"name":"Universit\u00e9 Paris-Saclay, INSERM, Physiopathog\u00e9n\u00e8se et traitement des maladies du Foie, Villejuif, France."},{"name":"FHU Hepatinov, Villejuif, France."},{"name":"Laboratoire d\u2019Anatomopathologie, AP-HP H\u00f4pital Paul-Brousse, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Antoine","family":"Allard","sequence":"additional","affiliation":[{"name":"AP-HP H\u00f4pital Paul-Brousse, Centre H\u00e9pato-Biliaire, Villejuif, France."},{"name":"INSERM, Universit\u00e9 Paris-Saclay, UMR-S 1193, Villejuif, France."},{"name":"Universit\u00e9 Paris-Saclay, INSERM, Physiopathog\u00e9n\u00e8se et traitement des maladies du Foie, Villejuif, France."},{"name":"FHU Hepatinov, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Golse","sequence":"additional","affiliation":[{"name":"AP-HP H\u00f4pital Paul-Brousse, Centre H\u00e9pato-Biliaire, Villejuif, France."},{"name":"INSERM, Universit\u00e9 Paris-Saclay, UMR-S 1193, Villejuif, France."},{"name":"Universit\u00e9 Paris-Saclay, INSERM, Physiopathog\u00e9n\u00e8se et traitement des maladies du Foie, Villejuif, France."},{"name":"FHU Hepatinov, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Azoulay","sequence":"additional","affiliation":[{"name":"AP-HP H\u00f4pital Paul-Brousse, Centre H\u00e9pato-Biliaire, Villejuif, France."},{"name":"INSERM, Universit\u00e9 Paris-Saclay, UMR-S 1193, Villejuif, France."},{"name":"Universit\u00e9 Paris-Saclay, INSERM, Physiopathog\u00e9n\u00e8se et traitement des maladies du Foie, Villejuif, France."},{"name":"FHU Hepatinov, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vibert","sequence":"additional","affiliation":[{"name":"AP-HP H\u00f4pital Paul-Brousse, Centre H\u00e9pato-Biliaire, Villejuif, France."},{"name":"INSERM, Universit\u00e9 Paris-Saclay, UMR-S 1193, Villejuif, France."},{"name":"Universit\u00e9 Paris-Saclay, INSERM, Physiopathog\u00e9n\u00e8se et traitement des maladies du Foie, Villejuif, France."},{"name":"FHU Hepatinov, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Charles","family":"Duclos Vallee","sequence":"additional","affiliation":[{"name":"AP-HP H\u00f4pital Paul-Brousse, Centre H\u00e9pato-Biliaire, Villejuif, France."},{"name":"INSERM, Universit\u00e9 Paris-Saclay, UMR-S 1193, Villejuif, France."},{"name":"Universit\u00e9 Paris-Saclay, INSERM, Physiopathog\u00e9n\u00e8se et traitement des maladies du Foie, Villejuif, France."},{"name":"FHU Hepatinov, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrille","family":"Feray","sequence":"additional","affiliation":[{"name":"AP-HP H\u00f4pital Paul-Brousse, Centre H\u00e9pato-Biliaire, Villejuif, France."},{"name":"INSERM, Universit\u00e9 Paris-Saclay, UMR-S 1193, Villejuif, France."},{"name":"Universit\u00e9 Paris-Saclay, INSERM, Physiopathog\u00e9n\u00e8se et traitement des maladies du Foie, Villejuif, France."},{"name":"FHU Hepatinov, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Samuel","sequence":"additional","affiliation":[{"name":"AP-HP H\u00f4pital Paul-Brousse, Centre H\u00e9pato-Biliaire, Villejuif, France."},{"name":"INSERM, Universit\u00e9 Paris-Saclay, UMR-S 1193, Villejuif, France."},{"name":"Universit\u00e9 Paris-Saclay, INSERM, Physiopathog\u00e9n\u00e8se et traitement des maladies du Foie, Villejuif, France."},{"name":"FHU Hepatinov, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Coilly","sequence":"additional","affiliation":[{"name":"AP-HP H\u00f4pital Paul-Brousse, Centre H\u00e9pato-Biliaire, Villejuif, France."},{"name":"INSERM, Universit\u00e9 Paris-Saclay, UMR-S 1193, Villejuif, France."},{"name":"Universit\u00e9 Paris-Saclay, INSERM, Physiopathog\u00e9n\u00e8se et traitement des maladies du Foie, Villejuif, France."},{"name":"FHU Hepatinov, Villejuif, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,1,26]]},"reference":[{"issue":"Suppl 1","key":"R1-20250604","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0168-8278(12)60004-X","article-title":"Management of hepatic vascular diseases.","volume":"56","author":"Plessier","year":"2012","journal-title":"J Hepatol"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00428-018-2331-3","article-title":"Vascular liver diseases on the clinical side: definitions and diagnosis, new concepts.","volume":"473","author":"Valla","year":"2018","journal-title":"Virchows Arch"},{"key":"R3-20250604","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jceh.2014.07.005","article-title":"Idiopathic non-cirrhotic intrahepatic portal hypertension (NCIPH)-newer insights into pathogenesis and emerging newer treatment options.","volume":"4","author":"Goel","year":"2014","journal-title":"J Clin Exp Hepatol"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.1840110512","article-title":"Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules.","volume":"11","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/hep.1840200206","article-title":"Histopathological study of intrahepatic aberrant vessels in cases of noncirrhotic portal hypertension.","volume":"20","author":"Ohbu","year":"1994","journal-title":"Hepatology"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2468-1253(19)30047-0","article-title":"Porto-sinusoidal vascular disease: proposal and description of a novel entity.","volume":"4","author":"Group","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.3748\/wjg.v17.i11.1400","article-title":"Nodular regenerative hyperplasia: evolving concepts on underdiagnosed cause of portal hypertension.","volume":"17","author":"Hartleb","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0168-8278(91)90916-Y","article-title":"Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients.","volume":"12","author":"Naber","year":"1991","journal-title":"J Hepatol"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/lt.21142","article-title":"Significance of nodular regenerative hyperplasia occurring de novo following liver transplantation.","volume":"13","author":"Devarbhavi","year":"2007","journal-title":"Liver Transpl"},{"key":"R10-20250604","first-page":"2510","article-title":"Nodular regenerative hyperplasia of the liver following orthotopic liver transplantation.","volume":"27","author":"Sebagh","year":"1995","journal-title":"Transplant Proc"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00595-019-01881-y","article-title":"Portal flow modulation in living donor liver transplantation: review with a focus on splenectomy.","volume":"50","author":"Yoshizumi","year":"2020","journal-title":"Surg Today"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/0016-5085(90)90029-Z","article-title":"Quantitation of the hepatic arterial buffer response to graded changes in portal blood flow.","volume":"98","author":"Lautt","year":"1990","journal-title":"Gastroenterology"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/physrev.00047.2009","article-title":"Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives.","volume":"91","author":"Chiu","year":"2011","journal-title":"Physiol Rev"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1097\/QAD.0b013e32832bfa51","article-title":"Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients.","volume":"23","author":"Mallet","year":"2009","journal-title":"AIDS"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5500\/wjt.v4.i1.30","article-title":"Immune monitoring post liver transplant.","volume":"4","author":"Sood","year":"2014","journal-title":"World J Transplant"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/000313480006601119","article-title":"Results of liver transplantation for nodular regenerative hyperplasia.","volume":"66","author":"Radomski","year":"2000","journal-title":"Am Surg"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.1840200114","article-title":"Nodular regenerative hyperplasia of the liver graft after liver transplantation.","volume":"20","author":"Gane","year":"1994","journal-title":"Hepatology"},{"key":"R18-20250604","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1432-2277.1994.tb01580.x","article-title":"Nodular regenerative hyperplasia: a controversial indication for orthotopic liver transplantation.","volume":"7","author":"Elariny","year":"1994","journal-title":"Transpl Int"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.dld.2011.04.004","article-title":"Liver transplantation for the treatment of nodular regenerative hyperplasia.","volume":"43","author":"Manzia","year":"2011","journal-title":"Dig Liver Dis"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/lt.21493","article-title":"A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients.","volume":"14","author":"Tateo","year":"2008","journal-title":"Liver Transpl"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/gut.51.2.275","article-title":"Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients.","volume":"51","author":"Hillaire","year":"2002","journal-title":"Gut"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"e13471","DOI":"10.1111\/petr.13471","article-title":"Clinicopathologic characteristics of de novo nodular regenerative hyperplasia in pediatric liver transplant.","volume":"23","author":"Gonz\u00e1lez","year":"2019","journal-title":"Pediatr Transplant"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/jamasurg.2018.5568","article-title":"Assessment of trends in transplantation of liver grafts from older donors and outcomes in recipients of liver grafts from older donors, 2003-2016.","volume":"154","author":"Haugen","year":"2019","journal-title":"JAMA Surg"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1432-2277.2005.00128.x","article-title":"Older liver graft transplantation, cholestasis and synthetic graft function.","volume":"18","author":"Borchert","year":"2005","journal-title":"Transpl Int"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/hep.21888","article-title":"Minimizing risk associated with elderly liver donors by matching to preferred recipients.","volume":"46","author":"Segev","year":"2007","journal-title":"Hepatology"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1097\/TP.0000000000002190","article-title":"Minimizing risk associated with older liver donors by matching to preferred recipients: a national registry and validation study.","volume":"102","author":"Haugen","year":"2018","journal-title":"Transplantation"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.coi.2010.05.003","article-title":"Aging of the innate immune system.","volume":"22","author":"Shaw","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"R28-20250604","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-6143.2010.03317.x","article-title":"Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression.","volume":"11","author":"Lo","year":"2011","journal-title":"Am J Transplant"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1006\/jsre.2002.6462","article-title":"Evaluation of the effect of age on functioning hepatocyte mass and liver blood flow using liver scintigraphy in preoperative estimations for surgical patients: comparison with CT volumetry.","volume":"106","author":"Wakabayashi","year":"2002","journal-title":"J Surg Res"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.tem.2009.01.005","article-title":"Aging and liver regeneration.","volume":"20","author":"Timchenko","year":"2009","journal-title":"Trends Endocrinol Metab"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/j.1600-6143.2006.01402.x","article-title":"Developments in clinical islet, liver thoracic, kidney and pancreas transplantation in the last 5 years.","volume":"6","author":"Feng","year":"2006","journal-title":"Am J Transplant"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1111\/j.1600-6143.2012.04195.x","article-title":"The Eurotransplant donor risk index in liver transplantation: ET-DRI.","volume":"12","author":"Braat","year":"2012","journal-title":"Am J Transplant"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/ajt.15297","article-title":"Geographic disparities in liver supply\/demand ratio within fixed-distance and fixed-population circles.","volume":"19","author":"Haugen","year":"2019","journal-title":"Am J Transplant"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1016\/j.transproceed.2015.10.004","article-title":"Liver transplantation outcomes using grafts from donors older than the age of 80 years.","volume":"47","author":"Rabelo","year":"2015","journal-title":"Transplant Proc"},{"issue":"Suppl 3","key":"R35-20250604","article-title":"Nodular regenerative hyperplasia after liver transplant \u2013 it is all in the presentation.","volume":"19","author":"Chen","year":"2019","journal-title":"Am J Transplant"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"2016 comprehensive update of the Banff Working Group on Liver Allograft Pathology: introduction of antibody-mediated rejection.","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transplant"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2169\/internalmedicine.51.5638","article-title":"Interstitial pneumonia and nodular regenerative hyperplasia of the liver as initial manifestations of polyarteritis nodosa.","volume":"51","author":"Tanaka","year":"2012","journal-title":"Intern Med"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/hepr.12045","article-title":"Hepatoportal sclerosis (obliterative portal venopathy) and nodular regenerative hyperplasia in a patient with myasthenia gravis: a case report and review of the published work.","volume":"43","author":"Agrawal","year":"2013","journal-title":"Hepatol Res"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/lt.24979","article-title":"Liver transplantation in adults with liver disease due to common variable immunodeficiency leads to early recurrent disease and poor outcome.","volume":"24","author":"Azzu","year":"2018","journal-title":"Liver Transpl"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s10875-013-9873-6","article-title":"Nodular regenerative hyperplasia in common variable immunodeficiency.","volume":"33","author":"Fuss","year":"2013","journal-title":"J Clin Immunol"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.3748\/wjg.v19.i22.3502","article-title":"Nodular regenerative hyperplasia related portal hypertension in a patient with hypogammaglobulinaemia.","volume":"19","author":"Lal","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12885-016-2998-2","article-title":"Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis.","volume":"17","author":"Stevenson","year":"2017","journal-title":"BMC Cancer"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/hep.30157","article-title":"Nodular regenerative hyperplasia associated with immune checkpoint blockade.","volume":"68","author":"LoPiccolo","year":"2018","journal-title":"Hepatology"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/2050640616680550","article-title":"Nodular regenerative hyperplasia rarely leads to liver transplantation: a 20-year cohort study in all Dutch liver transplant units.","volume":"5","author":"Meijer","year":"2017","journal-title":"United European Gastroenterol J"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1097\/01.TP.0000436930.53768.45","article-title":"Lengthy follow-up after liver transplantation for nodular regenerative hyperplasia in human immunodeficiency virus-infected patients: does the disease recur?","volume":"96","author":"Sultanik","year":"2013","journal-title":"Transplantation"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/hep4.1198","article-title":"Spleen and liver volumetrics as surrogate markers of hepatic venous pressure gradient in patients with noncirrhotic portal hypertension.","volume":"2","author":"Etzion","year":"2018","journal-title":"Hepatol Commun"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1475-097X.1985.tb00766.x","article-title":"Splenic haemodynamics and portal hypertension in patients with liver cirrhosis and spleen enlargement.","volume":"5","author":"Merkel","year":"1985","journal-title":"Clin Physiol"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1590-8658(02)80246-8","article-title":"Role of spleen enlargement in cirrhosis with portal hypertension.","volume":"34","author":"Bolognesi","year":"2002","journal-title":"Dig Liver Dis"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.cgh.2008.05.004","article-title":"Spleen enlargement on follow-up evaluation: a noninvasive predictor of complications of portal hypertension in cirrhosis.","volume":"6","author":"Berzigotti","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1440-1746.2010.06325.x","article-title":"Spleen stiffness measurement using Fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients.","volume":"26","author":"Stefanescu","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.ultrasmedbio.2018.03.028","article-title":"A novel FibroScan examination dedicated to spleen stiffness measurement.","volume":"44","author":"Bastard","year":"2018","journal-title":"Ultrasound Med Biol"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/liv.12936","article-title":"Obliterative portal venopathy without portal hypertension: an underestimated condition.","volume":"36","author":"Guido","year":"2016","journal-title":"Liver Int"},{"key":"R53-20250604","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.freeradbiomed.2013.05.034","article-title":"Mechanosensitive microRNAs-role in endothelial responses to shear stress and redox state.","volume":"64","author":"Marin","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"H1209","DOI":"10.1152\/ajpheart.01047.2006","article-title":"Mechanotransduction and endothelial cell homeostasis: the wisdom of the cell.","volume":"292","author":"Chien","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R55-20250604","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.3748\/wjg.v23.i18.3279","article-title":"Wall shear stress in portal vein of cirrhotic patients with portal hypertension.","volume":"23","author":"Wei","year":"2017","journal-title":"World J Gastroenterol"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:21:07Z","timestamp":1749061267000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000004303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000004303","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,26]]}}}